info@seagull-health.com
SeagullHealth
语言:
search
new
Indications for Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)
511
Article source: Seagull Pharmacy
Nov 06, 2025

Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR) is an innovative oral combination anti-diabetic formulation that integrates the dual advantages of a dipeptidyl peptidase-4 (DPP-4) inhibitor and a biguanide agent.

Indications for Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)

Primary Indication

Adjunctive treatment for type 2 diabetes in adults: Serving as an effective supplement to dietary control and exercise therapy, it is specifically indicated to improve blood glucose control in adult patients with type 2 diabetes.

Special Precautions

Contraindicated Populations: It must not be used for the treatment of patients with type 1 diabetes.

Risk of Pancreatitis: No systematic studies have been conducted in patients with a history of pancreatitis, so it cannot be determined whether the use of this drug in such patients will increase the risk of developing pancreatitis. A rigorous assessment of medication safety is necessary.

Dosage Strengths and Physical Characteristics of Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)

Sitagliptin 100 mg / Metformin Hydrochloride 1000 mg Extended-Release Tablets

Physical Appearance: Blue, biconvex, oval-shaped film-coated tablets.

Identification Marking: Imprinted with the code "81" on one side as an anti-counterfeiting mark.

Sitagliptin 50 mg / Metformin Hydrochloride 500 mg Extended-Release Tablets

Physical Appearance: Light blue, biconvex, oval-shaped film-coated tablets.

Identification Marking: Imprinted with the code "78" on one side.

Sitagliptin 50 mg / Metformin Hydrochloride 1000 mg Extended-Release Tablets

Physical Appearance: Light green, biconvex, oval-shaped film-coated tablets.

Identification Marking: Imprinted with the code "80" on one side.

Storage Instructions for Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)

Temperature Control Standards

Ideal Storage Temperature: 20°C to 25°C (68°F to 77°F).

Allowable Temperature Fluctuation Range: 15°C to 30°C (59°F to 86°F).

Storage Environment Requirements: Store in a dry area with the container tightly sealed.

Key Points for Packaging Management

Maintenance of Original Packaging: The original packaging must be retained, and the bottle cap must be kept tightly closed.

Child Safety Protection: Store the product in an area that is out of the reach of children.

Usage and Handling Specifications: Reseal the container immediately after each dose is taken.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
What Are the Side Effects of Tivozanib (Fotivda)?
Tivozanib (Fotivda) is a targeted therapy drug for recurrent or refractory advanced renal cell carcinoma, offering new hope to patients who have undergone multiple lines of systemic treatment. However...
Precautions for Administration of Tivozanib (Fotivda)
Tivozanib (Fotivda) is a kinase inhibitor. By targeting multiple tyrosine kinase targets such as vascular endothelial growth factor receptor (VEGFR), it inhibits tumor angiogenesis and is used for the...
How to Use Tivozanib (Fotivda)
Tivozanib (Fotivda) is a kinase inhibitor that was first approved in the United States in 2021. This medication is specifically indicated for the treatment of adult patients with advanced renal cell c...
Indications for Tivozanib Capsules (Fotivda)
Tivozanib Capsules (Fotivda) is a kinase inhibitor that was first approved in the United States in 2021. As an important drug for the treatment of advanced renal cell carcinoma, it blocks tumor angiog...
How to Use Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)
Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR) is a fixed-dose combination antihyperglycemic medication. It contains sitagliptin (a dipeptidyl peptidase-4 inhibitor) and met...
What Are the Side Effects of Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)?
Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR) is a fixed-dose combination preparation for the treatment of type 2 diabetes. It provides effective blood glucose control for ...
How to Purchase Enstilar
Enstilar is a prescription medication and must be obtained in strict compliance with medical regulatory procedures. It contains calcipotriene (a vitamin D analog) and betamethasone dipropionate (a cor...
Indications for Enstilar
Enstilar is an innovative topical fixed-dose combination preparation that integrates the dual effects of a vitamin D analog and a corticosteroid, specifically designed for the treatment of plaque psor...
Related Articles
Contraindications and Special Populations of Brensocatib Tablets
The prescribing information for Brixocatib tablets indicates that there are no absolute contraindications, but careful assessment of risks and benefits is still required in patients with special physi...
Dosage and Administration of Isatuximab Injection (Sarclisa)
Sarclisa must be administered under the supervision of a healthcare professional, and the administration site must be equipped with immediately available emergency equipment and medical support to man...
Indications and Dosage of Tepotinib
Tepotinib is an oral MET tyrosine kinase inhibitor indicated for the treatment of non-small cell lung cancer harboring MET exon 14 skipping mutations.I. Indications and Patient Selection1. Applicable ...
Dosage and Administration of Zidesamtinib
Before the first administration of Ziditnib, the following baseline assessments must be completed: serum creatine phosphokinase level, electrocardiogram, blood electrolytes (potassium, magnesium, calc...
Indications and Dosage and Administration of Ripretinib
Ripretinib is a kinase inhibitor specifically indicated for adult patients with advanced gastrointestinal stromal tumors who have previously received three or more kinase inhibitors.I. Indications and...
Contraindications and Medication in Special Populations of Ripretinib
Ripretinib does not list any absolute contraindications in its prescribing information, but there are clear usage restrictions or risks for specific physiological states and populations.I. Clear Contr...
Adverse Reactions of Ripretinib
Unlike traditional inhibition that targets the active site of a single kinase, ripretinib modulates the kinase "switch" conformation to suppress aberrant kinase signaling of KIT and PDGFRA, ...
Contraindications and Medication in Special Populations of Etoricoxib
Etoricoxib is effective for pain relief, but due to its cardiovascular and gastrointestinal risks, there are clear contraindications for its use.I. Absolute contraindications: who must not use it1. Al...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • haiousales@gmail.com
Welcome to consult
Seagull Pharmacy.,Ltd All rights reserved